Middle East Poultry Medicine Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Middle East Poultry Medicine Market Overview

• The Middle East Poultry Medicine Market is valued at USD 3.4 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for poultry products, rising awareness of animal health, and the need for disease prevention in poultry farming. The market is also influenced by advancements in veterinary medicine and the growing trend of biosecurity measures among poultry producers. Increasing investments in commercial poultry operations and the expansion of veterinary healthcare infrastructure are further accelerating market growth across the region .
• Key players in this market include Saudi Arabia, the United Arab Emirates, and Egypt. These countries dominate the market due to their large poultry production capacities, significant investments in the agricultural sector, and a growing consumer base that demands high-quality poultry products. Additionally, government support and favorable regulations in these regions further enhance their market position. Saudi Arabia, in particular, is witnessing rapid expansion in its poultry medicine sector, supported by rising meat consumption and modernization of farming practices .
• In 2023, the Saudi Arabian government implemented the Veterinary Medicines Regulation, 2023, issued by the Saudi Food and Drug Authority. This regulation mandates the use of veterinary medicines that comply with international standards and requires all poultry medicine products to undergo rigorous testing and approval processes before they can be marketed. The regulation aims to improve the quality of poultry products and ensure the safety of consumers, thereby enhancing the overall health standards in the poultry industry .

Middle East Poultry Medicine Market Segmentation

By Type:The market is segmented into various types of poultry medicines, including antibiotics, vaccines, antiparasitics, nutraceuticals, anti-inflammatories, growth promoters, hormones, and others. Among these, antibiotics and vaccines are the most widely used due to their critical role in disease prevention and treatment in poultry farming. The increasing prevalence of infectious diseases in poultry has led to a higher demand for these products, making them dominant in the market.

By End-User:The end-user segmentation includes commercial poultry farms, smallholder/backyard poultry farmers, veterinary clinics & hospitals, integrators, research institutions, and others. Commercial poultry farms are the leading segment, driven by the increasing demand for poultry meat and eggs, which necessitates the use of effective veterinary medicines to maintain flock health and productivity.

Middle East Poultry Medicine Market Competitive Landscape

The Middle East Poultry Medicine Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Virbac, Vetoquinol, Huvepharma, Phibro Animal Health Corporation, Biovet S.A., Al-Watania Poultry (Saudi Arabia), Almarai Company (Saudi Arabia), Kemin Industries, ADM Animal Nutrition, Tanmiah Food Company (Saudi Arabia) contribute to innovation, geographic expansion, and service delivery in this space.

Middle East Poultry Medicine Market Industry Analysis

Growth Drivers

• Increasing Poultry Production:The Middle East has seen a significant rise in poultry production, with an estimated output of 1.6 million tons in future, projected to reach 1.8 million tons by future. This growth is driven by the region's increasing population, which is expected to surpass 520 million in future, leading to higher protein demand. The poultry sector's expansion necessitates enhanced veterinary services and medicines to ensure animal health and productivity, thus driving the poultry medicine market.
• Rising Demand for Poultry Products:The demand for poultry products in the Middle East is projected to grow, with consumption expected to reach 2.3 million tons by future. Factors contributing to this trend include urbanization, changing dietary preferences, and increased disposable incomes. As consumers shift towards protein-rich diets, the need for effective poultry health management becomes critical, thereby boosting the demand for veterinary medicines and health products in the region.
• Advancements in Veterinary Medicine:The Middle East is witnessing rapid advancements in veterinary medicine, with investments in research and development reaching approximately $220 million in future. Innovations in vaccine development and treatment protocols are enhancing disease management in poultry. These advancements not only improve animal health outcomes but also increase productivity, thereby driving the demand for modern poultry medicines and veterinary services across the region.

Market Challenges

• High Cost of Veterinary Services:The cost of veterinary services in the Middle East can be prohibitive, with average treatment costs ranging from $60 to $220 per animal. This financial burden can deter poultry farmers, particularly small-scale operators, from seeking necessary medical care for their flocks. Consequently, this challenge limits the overall effectiveness of poultry health management and can lead to increased disease prevalence, negatively impacting the poultry medicine market.
• Regulatory Compliance Issues:Navigating the complex regulatory landscape poses significant challenges for poultry medicine providers in the Middle East. Compliance with veterinary drug approval processes can take up to 20 months, delaying the introduction of new products. Additionally, stringent biosecurity regulations require substantial investment from poultry producers, which can hinder market growth. These compliance issues create barriers to entry for new veterinary products and services, affecting overall market dynamics.

Middle East Poultry Medicine Market Future Outlook

The future of the Middle East poultry medicine market appears promising, driven by increasing investments in veterinary healthcare and a growing focus on sustainable practices. As the region's poultry industry expands, there will be a heightened emphasis on preventive healthcare measures and innovative treatment solutions. Additionally, the integration of technology in veterinary services is expected to enhance efficiency and effectiveness, paving the way for improved animal health outcomes and market growth in the coming years.

Market Opportunities

• Growth in Organic Poultry Farming:The organic poultry farming sector is gaining traction, with an estimated growth rate of 18% annually. This trend presents opportunities for specialized veterinary products that cater to organic standards, allowing companies to tap into a niche market that prioritizes animal welfare and sustainable practices, thus enhancing their competitive edge.
• Expansion of Veterinary Services:The expansion of veterinary services in rural areas is crucial, with an estimated 35% of poultry farms lacking access to professional veterinary care. By increasing service availability and outreach, companies can address this gap, fostering better health management practices and driving demand for veterinary medicines, ultimately benefiting the entire poultry sector.